ArticleBreast cancer research : BCR2023

The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling.

Deeksha Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.